First Manhattan
AXSM icon

First Manhattan’s Axsome Therapeutics AXSM Stock Holding History

First Manhattan’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300
Closed -$23.9K – 715
2024
Q1 		$23.9K Hold
300
– – ﹤0.01% 1005
2023
Q4 		$23.9K Hold
300
– – ﹤0.01% 994
2023
Q3 		$21K Buy
300
+200
+200% +$15K ﹤0.01% 1016
2023
Q2 		$7.19K Hold
100
– – ﹤0.01% 1185
2023
Q1 		$6.17K Buy
+100
New +$6.57K ﹤0.01% 1265
2019
Q1 		– Sell
-1,100
Closed -$3K – 1385
2018
Q4 		$3K Buy
+1,100
New +$3.62K ﹤0.01% 1266

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return